CoreValve Out in Front with Non-Invasive Heart Valve

CoreValve received CE Mark approval yesterday for its non-invasive heart valve, putting the Irvine, CA, company out in front of other startups working on similar technologies. The company’s ReValving System inserts the artificial valve through a catheter and permanently implants it over the...

Robotic Devices Move Into the Mainstream…and Beyond

Cardiogenesis, an Irvine, CA-based medical device company that specializes in devices that stimulate cardiac angiogenesis, submitted a PMA last week for its minimally invasive Robotic 5.0 PEARL Delivery System. The PEARL, which stands for Port Enabled Angina Relief, uses Cardiogenesis’ Transmyocardial...

Amedica Secures $13.2 Million in Series D Financing

Amedica, a Salt Lake City, UT, company that makes orthopedic implants, today announced that it has raised $13.2 million in Series D financing. Including this round, for which Creation Capital served as the placement agent, Amedica has raised roughly $44 million since November 2003. The company will spend...

Teknimed Inks Deal with Smith & Nephew

Teknimed, a privately held French company that makes biomaterials for bone surgery, has signed a deal to allow Smith & Nephew to market its FDA-approved bone cement. Smith & Nephew’s Orthopaedic Trauma & Clinical Therapies division will distribute, market and sell the product, called Spine...

CEO Says Private Placement Forgives ‘Hiccups’

Bruce Kehr, CEO of Rockville, MD-based InforMedix, thinks private placement funding is worth the wait. The neuropsychiatrist turned CEO recently explained to the Washington Business Journal his company’s strategy of sticking with private placements over convertible debt. In an article that ran on...

BlueSky May Make $110 Million off Smith & Nephew Deal

The two founders of BlueSky Medical Group, a private med tech company based in Carlsbad, CA, stand to make up to $110 million off a deal with Smith & Nephew. The British giant announced today that it has agreed to buy BlueSky, which makes products for treating chronic wounds using megative pressure...

Schwarz Out in Front with Parkinson’s Patch

Schwarz Pharma today received FDA approval for Neupro, its transdermal patch for treatment of early-stage Parkinson’s disease. Neupro has been on the market in Europe since March 2006 and was approved there for all stages of Parkinson’s in January 2007. In the U.S., Schwarz will submit a...

‘Banner Day’ of Funding for Life Sciences Startups

Yesterday, according to Red Herring, was “a banner day for life sciences companies searching for money,” with companies from the U.S., Canada, Germany and India announcing funding. Asmacure, of Quebec City, announced a Series A financing of $9 million, which it will use to support R&D of its...